feed,title,long_url,short_url
gNews,Coherus BioSciences (NASDAQ:CHRS) Stock Falls on Delay in FDA Review of Toripalimab BLA - TipRanks,https://www.tipranks.com/news/coherus-biosciences-nasdaqchrs-stock-falls-on-delay-in-fda-review-of-toripalimab-bla,https://da.gd/cGjbf
